0028sek
-9,2 %
Date:2025-10-14Time:14:53:52Latest report:Q2-2025List:First NorthTicker:GABA
Market Cap:7 msekEnterprise Value:4 msekNet Sales:- msekEarnings:-4,49 msekEmployees:0ISIN:SE0010869552

Ratios

10-year key figure history for Gabather turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Gabather with index and moving average MA50 and MA200.

Stockprice:0,028
MA50:0,04
MA200:0,10
Price/MA200:-71,3 %
RSI (14):28,9
Price/MA50:-31,1 %

Description

Gabather is a pharmaceutical company whose business focus is to develop drug candidates for the treatment of neurological diseases. The focus is particularly on the stimulation of gamma-aminobutyric acid, which is the main inhibitory neurotransmitter in the brain. The drug candidates are patented on a global level. Gabather was established in 2014 and is headquartered in Malmö.

Biotechnology